Kumar R, Brown S R, Patel M V. "Method for the Synthesis of Dasatinib Impurity 25" [P]. US Patent, US 9271947 B2, 2015-02-08.
发明人朱建伟,徐明华,唐晓军. "A Process for Preparing High-Purity Dasatinib Impurity 25" [P]. 中国发明专利, 专利号 CN 115554633 B, 授权公告日 2021-07-22.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质25 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 1554, (2), 7948-7967.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质25 as an Impurity". J. Sep. Sci., 2017, 1921, (2), 4753-4783.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 25 Using HRMS and NMR". Chromatographia, 2021, 501, (1), 8356-8374.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 达沙替尼杂质25 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 1193, 7061-7083.